In this regard, sustained inhibition of the critical DNA repair regulator ERCC6 may be one of the key mechanisms contributing to the anticancer efficacy of FL118 in the drug-resistant pancreatic cancer. The gene discussed is ERCC6; the disease is familial pancreatic carcinoma.